MyFinsight
Home
Blog
About
Marketable securities
$245,095K
(-13.85%↓ Y/Y)
Cash and cash
equivalents
$204,595K
(111.69%↑ Y/Y)
Accounts receivable, net
$96,028K
(64.62%↑ Y/Y)
Prepaid expenses
$9,613K
(-67.05%↓ Y/Y)
Inventory
$4,377K
(13.01%↑ Y/Y)
Other receivables
$2,281K
(19.67%↑ Y/Y)
Total current assets
$561,989K
(18.46%↑ Y/Y)
Property and equipment,
net
$20,489K
(543.90%↑ Y/Y)
Operating lease
right-of-use assets
$9,911K
(4227.95%↑ Y/Y)
Intangible assets, net
$6,885K
(-12.25%↓ Y/Y)
Long-term investments
$6,682K
(122.73%↑ Y/Y)
Inventory, non-current
$2,525K
(-0.28%↓ Y/Y)
Restricted cash,
non-current
$2,001K
(-21.93%↓ Y/Y)
Other assets
$660K
(-45.59%↓ Y/Y)
Total assets
$611,142K
(23.46%↑ Y/Y)
Total liabilities and
stockholders equity
$611,142K
(23.46%↑ Y/Y)
Total stockholders
equity
$346,732K
(4.25%↑ Y/Y)
Total liabilities
$264,410K
(62.83%↑ Y/Y)
Accumulated deficit
-$452,146K
(-11.46%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$557K
(-1528.21%↓ Y/Y)
Additional paid-in capital
$799,429K
(8.29%↑ Y/Y)
Total current
liabilities
$175,753K
(94.73%↑ Y/Y)
Long-term debt, net
$72,762K
(0.88%↑ Y/Y)
Other long-term
liabilities
$15,895K
Common stock, 0.0001
par value...
$6K
(0.00%↑ Y/Y)
Other accrued
liabilities
$123,725K
(57.33%↑ Y/Y)
Accounts payable
$40,141K
Accrued payroll and
benefits
$11,887K
(2.37%↑ Y/Y)
Back
Back
Balance Sheet
Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS)
source: myfinsight.com